Quarterly report [Sections 13 or 15(d)]

Stock Based Compensation

v3.25.3
Stock Based Compensation
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation
11.
Stock-Based Compensation

In connection with the Merger, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (the “2021 ESPP”). The number of shares available for issuance under the 2021 Plan is increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount as provided in the 2021 Plan. Pursuant to this automatic increase feature of the 2021 Plan, 1,285,558 shares were added as available for issuance thereunder on January 1, 2025. As of June 30, 2025, 1,247,439 shares were available for issuance under the 2021 Plan.

The number of shares available for issuance under the 2021 ESPP is increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount as provided in the 2021 ESPP. Pursuant to this automatic increase feature of the 2021 ESPP, 257,111 shares were added as available for issuance thereunder on January 1, 2025. As of June 30, 2025, 803,675 shares were available for issuance under the 2021 ESPP.

The following table summarizes stock option activity under our equity compensation plans:

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate Intrinsic Value ('000)

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Options outstanding as of December 31, 2024

 

 

1,978,557

 

 

$

16.72

 

 

 

4.5

 

 

 

 

Granted

 

 

21,650

 

 

$

11.00

 

 

 

 

 

 

 

Exercised

 

 

(105,541

)

 

$

8.24

 

 

 

 

 

 

 

Forfeited, canceled, or expired

 

 

(105,747

)

 

$

18.08

 

 

 

 

 

 

 

Options outstanding as of June 30, 2025

 

 

1,788,919

 

 

$

17.08

 

 

 

4.1

 

 

$

1,378

 

Vested and expected to vest at June 30, 2025

 

 

1,788,919

 

 

$

17.08

 

 

 

4.1

 

 

$

1,378

 

Exercisable at June 30, 2025

 

 

1,766,518

 

 

$

17.13

 

 

 

4.0

 

 

$

1,359

 

The aggregate intrinsic value of options exercised was $155 and $493 during the three and six months ended June 30, 2025, respectively, and was $0 and $189 during the three and six months ended June 30, 2024, respectively. The cash proceeds from the options exercised was $230 and $870 during the three and six months ended June 30, 2025, respectively, and $2 and $269 during the three and six months ended June 30, 2024, respectively. The aggregate fair value of options vested was $243 and $371 during the three and six months ended June 30, 2025, respectively, and $922 and $1,686 during the three and six months ended June 30, 2024, respectively. There were 21,650 and 33,901 options granted during the three and six months ended June 30, 2025 and 2024, respectively.

The following table summarizes restricted stock unit (“RSU”) activity under the 2021 Plan:

 

 

 

 

Number of RSUs

 

 

Weighted Average Grant Date Fair Value per Share

 

Outstanding as of December 31, 2024

 

 

 

 

2,777,156

 

 

$

10.32

 

RSUs granted

 

 

 

 

1,251,385

 

 

$

12.10

 

RSUs and PSUs vested

 

 

 

 

(852,136

)

 

$

11.42

 

RSUs forfeited

 

 

 

 

(557,131

)

 

$

9.98

 

Outstanding as of June 30, 2025

 

 

 

 

2,619,274

 

 

$

10.88

 

For RSUs with service-based vesting conditions, the fair value is calculated based upon the Company’s closing stock price on the date of grant, and the stock-based compensation expense is recognized over the applicable grant vesting term, generally three to four years. For performance stock units (“PSUs”), the awards vest based on the achievement of certain performance goals over a specified period, generally ranging from four to five years. The fair value of PSUs is calculated based on the Company’s closing stock price on the grant date. Stock-based compensation expense is recognized over the applicable vesting period based on the number of units expected to vest. The aggregate fair value of RSUs and PSUs vested was $5,164 and $8,905 during the three and six months ended June 30, 2025, respectively, and $1,847 and $4,343 during the three and six months ended June 30, 2024, respectively.

As of June 30, 2025, there was $24,845 of total unrecognized compensation expense related to options, RSUs, and PSUs expected to be recognized over a weighted average period of 2.2 years.

The following table summarizes the components of total stock-based compensation expense based on roles and responsibilities of the employees within the condensed consolidated statements of operations:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenue

 

$

79

 

 

$

63

 

 

$

192

 

 

$

124

 

Research and development

 

 

837

 

 

 

1,210

 

 

 

1,662

 

 

 

2,228

 

Sales and marketing

 

 

490

 

 

 

944

 

 

 

1,968

 

 

 

1,619

 

General and administrative

 

 

4,816

 

 

 

2,578

 

 

 

7,305

 

 

 

4,452

 

 

$

6,222

 

 

$

4,795

 

 

$

11,127

 

 

$

8,423